Results 171 to 180 of about 14,810 (242)

Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials

, 2019
Susan Stienen, Patrick Rossignol, António S. Barros, Nicolas Girerd, Bertram Pitt, Faı̈ez Zannad, João Pedro Ferreira   +6 more
openalex   +2 more sources

Glomerular Disease and Cystic Kidney Disease: From Pathogenesis to Novel Therapeutic Approaches. [PDF]

Biomedicines
Filiopoulos V.
europepmc   +1 more source

Rouge on the Lips of Silence. [PDF]

J Grad Med Educ
Teramoto Y.
europepmc   +1 more source

Comparing the Long-Term Effectiveness of Sodium-Glucose Cotransporter 2 Inhibitors Versus Mineralocorticoid Receptor Antagonists as Add-On Therapies in the Management of Heart Failure: A Systematic Review. [PDF]

Cureus
George V, Pillai MH, Jacob V, Mp R, Vasant A, Adnan H.   +5 more
europepmc   +1 more source

Different aspects of pharmacological heart failure treatment. [PDF]

Eur Heart J Cardiovasc Pharmacother
Agewall S.
europepmc   +1 more source

Investigating the efficacy of mineralocorticoid receptor antagonists for cardiovascular outcomes in different diseases. [PDF]

ESC Heart Fail
Wang J, Zheng M, Yang Y, Zhang L, Wulasihan M.   +4 more
europepmc   +1 more source

Development and validation of RP-HPLC method for estimation of eplerenone in spiked human plasma

, 2012
Paraag Gide, Sandeep Sonawane, A.S. Chitnis   +2 more
openalex   +1 more source

Cardiovascular Outcomes and Hyperkalemia Risk in Patients With Diabetes, Chronic Kidney Disease and Heart Failure: A Real-World Comparison of Non-steroidal versus Steroidal Mineralocorticoid Receptor Antagonists. [PDF]

Cureus
Okunlola AO, Kolawole O, Otabor E, Hassan A, Hamilton M, Alomari L, Lam J, Idowu AB.   +7 more
europepmc   +1 more source

Cardiovascular-Kidney-Metabolic Effects: Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists. [PDF]

Rev Cardiovasc Med
Bozkurt B, Januzzi JL, Bansal S.
europepmc   +1 more source

The Importance of Early Diagnosis and Treatment to Limit the Impact of Dystrophic Cardiomyopathy-We've Seen This Film Before, and We Didn't Like the Ending. [PDF]

J Cardiovasc Dev Dis
Townsend D.
europepmc   +1 more source